← Back to Discover
Remedium Capital Partners, LLC
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $273,591,243
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Spyre Therapeutics Inc · COM · 00773J202 · shares: $103,329,999
- Oruka Therapeutics Inc · COM · 687604108 · shares: $79,471,154
- Damora Therapeutics Inc · COM · G2646Y104 · shares: $43,527,665
- Jade Biosciences Inc · COM · 008064206 · shares: $25,399,787
- Korsana Biosciences Inc · COM · 23255M303 · shares: $16,592,000
- Crescent Biopharma Inc · COM · G2545C104 · shares: $5,270,638
Reported holdings
6 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Spyre Therapeutics Inc | COM | 00773J202 | — | 1,160,620 shares | $103,329,999 |
| Oruka Therapeutics Inc | COM | 687604108 | — | 954,150 shares | $79,471,154 |
| Damora Therapeutics Inc | COM | G2646Y104 | — | 2,045,473 shares | $43,527,665 |
| Jade Biosciences Inc | COM | 008064206 | — | 1,807,814 shares | $25,399,787 |
| Korsana Biosciences Inc | COM | 23255M303 | — | 518,500 shares | $16,592,000 |
| Crescent Biopharma Inc | COM | G2545C104 | — | 361,250 shares | $5,270,638 |